{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:23:11Z","timestamp":1762273391710,"version":"3.35.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,31]]},"DOI":"10.7759\/cureus.78301","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T21:51:11Z","timestamp":1738360271000},"source":"Crossref","is-referenced-by-count":2,"title":["Reactive Infectious Mucocutaneous Eruption (RIME) in an Adult Male With Mycoplasma pneumoniae: A Case Report"],"prefix":"10.7759","author":[{"given":"Saud","family":"Alawad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nawaf","family":"Alsaeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bailey","family":"Burnette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Colantonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay","family":"Kasson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11040964","article-title":"Clinical differences between community-acquired Mycoplasma pneumoniae pneumonia and COVID-19 pneumonia","volume":"11","author":"Miyashita N","year":"2022","unstructured":"Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A, Ishiura Y, Nomura S. Clinical differences between community-acquired Mycoplasma pneumoniae pneumonia and COVID-19 pneumonia. J Clin Med. 2022, 11:10.3390\/jcm11040964","journal-title":"J Clin Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9122553","article-title":"Pulmonary and extrapulmonary manifestations in hospitalized children with Mycoplasma pneumoniae infection","volume":"9","author":"Biagi C","year":"2021","unstructured":"Biagi C, Cavallo A, Rocca A, et al.. Pulmonary and extrapulmonary manifestations in hospitalized children with Mycoplasma pneumoniae infection. Microorganisms. 2021, 9:2553. 10.3390\/microorganisms9122553","journal-title":"Microorganisms"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.10.007","article-title":"Reactive infectious mucocutaneous eruption secondary to SARS-CoV-2","volume":"18","author":"Ryder CY","year":"2021","unstructured":"Ryder CY, Pedersen EA, Mancuso JB. Reactive infectious mucocutaneous eruption secondary to SARS-CoV-2. JAAD Case Rep. 2021, 18:103-5. 10.1016\/j.jdcr.2021.10.007","journal-title":"JAAD Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(23)00344-0","article-title":"Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions","volume":"5","author":"Meyer Sauteur PM","year":"2024","unstructured":"Meyer Sauteur PM, Beeton ML. Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions. Lancet Microbe. 2024, 5:e100-1. 10.1016\/S2666-5247(23)00344-0","journal-title":"Lancet Microbe"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8091351","article-title":"Mycoplasmas-host interaction: mechanisms of inflammation and association with cellular transformation","volume":"8","author":"Benedetti F","year":"2020","unstructured":"Benedetti F, Curreli S, Zella D. Mycoplasmas-host interaction: mechanisms of inflammation and association with cellular transformation. Microorganisms. 2020, 8:1351. 10.3390\/microorganisms8091351","journal-title":"Microorganisms"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/cup.14339","article-title":"Reactive infectious mucocutaneous eruption due to COVID-19 with erythema-multiforme-like lesions and myeloid cells","volume":"50","author":"Ortiz EG","year":"2023","unstructured":"Ortiz EG, Junkins-Hopkins JM. Reactive infectious mucocutaneous eruption due to COVID-19 with erythema-multiforme-like lesions and myeloid cells. J Cutan Pathol. 2023, 50:321-5. 10.1111\/cup.14339","journal-title":"J Cutan Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003983","article-title":"Antibody responses to Mycoplasma pneumoniae: role in pathogenesis and diagnosis of encephalitis?","volume":"10","author":"Meyer Sauteur PM","year":"2014","unstructured":"Meyer Sauteur PM, Jacobs BC, Spuesens EB, Jacobs E, Nadal D, Vink C, van Rossum AM. Antibody responses to Mycoplasma pneumoniae: role in pathogenesis and diagnosis of encephalitis?. PLoS Pathog. 2014, 10:e1003983. 10.1371\/journal.ppat.1003983","journal-title":"PLoS Pathog"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57090895","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of diagnosis and management","volume":"57","author":"Frantz R","year":"2021","unstructured":"Frantz R, Huang S, Are A, Motaparthi K. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of diagnosis and management. Medicina (Kaunas). 2021, 57:895. 10.3390\/medicina57090895","journal-title":"Medicina (Kaunas)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v9.i15.3546","article-title":"Effectiveness of adjunctive corticosteroid therapy in patients with severe COVID-19: A retrospective cohort study","volume":"9","author":"Xiong B","year":"2021","unstructured":"Xiong B, He LM, Qin YY, et al.. Effectiveness of adjunctive corticosteroid therapy in patients with severe COVID-19: A retrospective cohort study. World J Clin Cases. 2021, 9:3546-58. 10.12998\/wjcc.v9.i15.3546","journal-title":"World J Clin Cases"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X221117887","article-title":"Reactive infectious mucocutaneous eruption - repeat etanercept after intravenous immunoglobulin: A case report","volume":"10","author":"Tonkin R","year":"2022","unstructured":"Tonkin R, Ladha M, Johnson N, et al.. Reactive infectious mucocutaneous eruption - repeat etanercept after intravenous immunoglobulin: A case report. SAGE Open Med Case Rep. 2022, 10:2050313X221117887. 10.1177\/2050313X221117887","journal-title":"SAGE Open Med Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/337598-reactive-infectious-mucocutaneous-eruption-rime-in-an-adult-male-with-mycoplasma-pneumoniae-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T21:51:12Z","timestamp":1738360272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/337598-reactive-infectious-mucocutaneous-eruption-rime-in-an-adult-male-with-mycoplasma-pneumoniae-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.78301","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,31]]}}}